{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:18:08Z","timestamp":1790320688625,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"am","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.annpat.2020.02.022","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T08:20:56Z","timestamp":1584519656000},"page":"148-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Les cancers du rein h\u00e9r\u00e9ditaires vus par le pathologiste en 2020"],"prefix":"10.1016","volume":"40","author":[{"given":"Virginie","family":"Verkarre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Morini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Denize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Ferlicot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annpat.2020.02.022_bib0455","unstructured":"Rapport - Volume 1 - Tumeurs solides - Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990\u00a0et 2018 - juillet 2019 - Ref\u00a0: RATSINCNAT19 [Internet]. Disponible sur\u00a0: https:\/\/www.e-cancer.fr\/Expertises-et-publications\/Catalogue-des-publications\/Rapport-Volume-1-Tumeurs-solides-Estimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-France-metropolitaine-entre-1990-et-2018-juillet-2019."},{"key":"10.1016\/j.annpat.2020.02.022_bib0460","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016\u00a0WHO Classification of Tumours of the Urinary System and Male Genital Organs\u2014Part A: Renal, Penile, and Testicular Tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0465","unstructured":"Recommandations fran\u00e7aises du comit\u00e9 de canc\u00e9rologie de l\u2019AFU\u2013Actualisation 2018\u20132020\u00a0: prise en charge du cancer du rein|Urofrance [Internet]. Disponible sur\u00a0: https:\/\/www.urofrance.org\/base-bibliographique\/recommandations-francaises-du-comite-de-cancerologie-de-lafu-actualisation-6."},{"key":"10.1016\/j.annpat.2020.02.022_bib0470","first-page":"106","article-title":"WHO classification of tumours of the urinary system and male genital organs","volume":"Vol. 70","author":"Moch","year":"2016"},{"key":"10.1016\/j.annpat.2020.02.022_bib0475","unstructured":"Predir [Internet]. Disponible sur\u00a0: http:\/\/www.predir.org\/View\/index.aspx."},{"key":"10.1016\/j.annpat.2020.02.022_bib0480","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1101\/gr.131110.111","article-title":"Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics","volume":"22","author":"Linehan","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.annpat.2020.02.022_bib0485","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.eururo.2019.06.015","article-title":"Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights","volume":"76","author":"Carlo","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0490","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1158\/2159-8290.CD-14-1096","article-title":"Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma","volume":"5","author":"Jafri","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.annpat.2020.02.022_bib0495","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/hmg\/ddi057","article-title":"Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas","volume":"14","author":"Rebouissou","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.annpat.2020.02.022_bib0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.03.039","article-title":"Pathogenic germline variants in 10,389\u00a0adult cancers","volume":"173","author":"Huang","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.annpat.2020.02.022_bib0505","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaoncol.2018.1986","article-title":"Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma","volume":"4","author":"Carlo","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0510","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/jmedgenet-2014-102912","article-title":"A germline mutation in PBRM1\u00a0predisposes to renal cell carcinoma","volume":"52","author":"Benusiglio","year":"2015","journal-title":"J Med Genet"},{"key":"10.1016\/j.annpat.2020.02.022_bib0515","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/his.13432","article-title":"Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28\u00a0cases","volume":"72","author":"Trpkov","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2020.02.022_bib0520","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/PAS.0000000000000870","article-title":"Biphasic Squamoid Alveolar Renal Cell Carcinoma: 2\u00a0Cases in a Family Supporting a Continuous Spectrum With Papillary Type I Renal Cell Carcinoma","volume":"41","author":"Chartier","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0525","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57\u00a0separate carcinomas in 18\u00a0patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0530","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"38","author":"Yang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0535","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/cancers12010168","article-title":"ESC, ALK, HOT and LOT: Three Letter Acronyms of Emerging Renal Entities Knocking on the Door of the WHO Classification","volume":"12","author":"Siadat","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.annpat.2020.02.022_bib0540","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.clon.2019.07.010","article-title":"Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database","volume":"32","author":"Kushnir","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0545","first-page":"442","article-title":"[Cancer genetic screening for patient with multiple renal tumors: what is the current practice for what results?]","volume":"26","author":"Beaugerie","year":"2016","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0550","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1002\/cncr.30893","article-title":"Advances in the diagnosis of hereditary kidney cancer: initial results of a multigene panel test: Multigene Panel Test for Kidney Cancer","volume":"123","author":"Nguyen","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2020.02.022_bib0555","unstructured":"Oncog\u00e9n\u00e9tique en 2015 - Consultations et laboratoires - Ref\u00a0: ONCOGENCONLAB16 [Internet]. Disponible sur\u00a0: https:\/\/www.e-cancer.fr\/Expertises-et-publications\/Catalogue-des-publications\/Oncogenetique-en-2015-Consultations-et-laboratoires."},{"key":"10.1016\/j.annpat.2020.02.022_bib0560","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0022-5347(05)67892-5","article-title":"Renal cell carcinoma: prognostic significance of incidentally detected tumors","volume":"163","author":"Tsui","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0565","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.juro.2012.08.030","article-title":"Succinate dehydrogenase kidney cancer: an aggressive example of the warburg effect in cancer","volume":"188","author":"Ricketts","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0570","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/PAS.0000000000000292","article-title":"Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma: A Morphologically Distinct Entity","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0575","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41588-018-0170-4","article-title":"Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair","volume":"50","author":"Sulkowski","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.annpat.2020.02.022_bib0580","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","article-title":"The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia","volume":"37","author":"Srigley","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0585","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/381054","article-title":"Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma","volume":"74","author":"Vanharanta","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.annpat.2020.02.022_bib0590","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/his.13277","article-title":"Succinate dehydrogenase (SDH)-deficient neoplasia","volume":"72","author":"Gill","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2020.02.022_bib0595","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/humu.21136","article-title":"Tumor risks and genotype-phenotype-proteotype analysis in 358\u00a0patients with germline mutations in SDHB and SDHD","volume":"31","author":"Ricketts","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.annpat.2020.02.022_bib0600","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","article-title":"An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis","volume":"10","author":"van Nederveen","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0605","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.humpath.2019.07.004","article-title":"Incidence of succinate dehydrogenase and fumarate hydratase\u2013deficient renal cell carcinoma based on immunohistochemical screening with SDHA\/SDHB and FH\/2SC","volume":"91","author":"Gupta","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0610","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/modpathol.2014.86","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11\u00a0tumors defining a unique subtype of renal cell carcinoma","volume":"28","author":"Williamson","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0615","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5114\/pjp.2016.59227","article-title":"Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects","volume":"1","author":"Kuroda","year":"2016","journal-title":"Pol J Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0620","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.annpat.2020.02.022_bib0625","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/jmg.2010.085068","article-title":"mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2\u00a0papillary renal cell carcinoma","volume":"48","author":"Gardie","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.annpat.2020.02.022_bib0630","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The Morphologic Spectrum of Kidney Tumors in Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC) Syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0635","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","article-title":"Fumarate Hydratase\u2013deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0640","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/cge.13014","article-title":"Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers","volume":"92","author":"Muller","year":"2017","journal-title":"Clin Genet"},{"key":"10.1016\/j.annpat.2020.02.022_bib0645","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/PAS.0000000000001372","article-title":"A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32\u00a0Patients","volume":"44","author":"Lau","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0650","article-title":"Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185\u00a0Affected Individuals","author":"Forde","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0655","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41379-018-0017-7","volume":"31","author":"Muller","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0660","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/gcc.22452","article-title":"Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma","volume":"56","author":"Vocke","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.annpat.2020.02.022_bib0665","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/his.13183","article-title":"A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma","volume":"71","author":"Smith","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2020.02.022_bib0670","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0675","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.humpath.2018.04.004","article-title":"SWI\/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32\u00a0tumors from 28\u00a0patients","volume":"77","author":"Agaimy","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0680","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcancer.2012.05.005","article-title":"Von Hippel-Lindau: how a rare disease illuminates cancer biology","volume":"23","author":"Richard","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0685","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.annpat.2020.02.022_bib0690","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMra043172","article-title":"Renal-cell carcinoma","volume":"353","author":"Cohen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annpat.2020.02.022_bib0695","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annpat.2020.02.022_bib0700","first-page":"330","article-title":"[Von Hippel-Lindau disease and renal cancer: 10\u00a0years of genetic progress. GEFVHL (French-Speaking Study Group on von Hippel-Lindau disease)]","volume":"8","author":"Richard","year":"1998","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0705","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.humpath.2014.06.004","article-title":"Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome \u2013 clinicopathological features and comparative genomic analysis of 3\u00a0cases","volume":"45","author":"Rao","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0710","first-page":"1","article-title":"Clear Cell Papillary Renal Cell Carcinoma: A Recent Entity With Distinct Imaging Patterns","author":"Tordjman","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0715","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13023-019-1206-2","article-title":"Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma","volume":"14","author":"Schuhmacher","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.annpat.2020.02.022_bib0720","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0022-5347(01)66674-6","article-title":"Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications","volume":"154","author":"Walther","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0725","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.ju.0000132127.79974.3f","article-title":"The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease","volume":"172","author":"Duffey","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0730","doi-asserted-by":"crossref","first-page":"11588","DOI":"10.1038\/ncomms11588","article-title":"Patient-specific factors influence somatic variation patterns in von Hippel-Lindau disease renal tumours","volume":"7","author":"Fei","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.annpat.2020.02.022_bib0735","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s13059-014-0433-z","article-title":"Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution","volume":"15","author":"Fisher","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0740","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/PAS.0000000000000514","article-title":"Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis","volume":"39","author":"Williamson","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0745","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13023-014-0163-z","article-title":"Renal cell tumour characteristics in patients with the Birt-Hogg-Dub\u00e9 cancer susceptibility syndrome: a retrospective, multicentre study","volume":"9","author":"Benusiglio","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.annpat.2020.02.022_bib0750","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2017.09.044","article-title":"FLCN: The causative gene for Birt-Hogg-Dub\u00e9 syndrome","volume":"640","author":"Schmidt","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.annpat.2020.02.022_bib0755","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1093\/hmg\/ddy181","article-title":"BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genes","volume":"27","author":"Hasumi","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.annpat.2020.02.022_bib0760","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","article-title":"Renal tumors in the Birt-Hogg-Dub\u00e9 syndrome","volume":"26","author":"Pavlovich","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0765","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jmg.2007.054304","article-title":"BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dub\u00e9 syndrome: a new series of 50\u00a0families and a review of published reports","volume":"45","author":"Toro","year":"2008","journal-title":"J Med Genet"},{"key":"10.1016\/j.annpat.2020.02.022_bib0770","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/01.ju.0000139583.63354.e0","article-title":"Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene","volume":"172","author":"Schmidt","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0775","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.annpat.2020.02.022_bib0780","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9440(10)65147-4","article-title":"Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype","volume":"155","author":"Lubensky","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0785","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0022-5347(05)68930-6","article-title":"Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery","volume":"161","author":"Walther","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0790","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2012.43.3383","article-title":"Phase II and biomarker study of the dual MET\/VEGFR2\u00a0inhibitor foretinib in patients with papillary renal cell carcinoma","volume":"31","author":"Choueiri","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0795","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1158\/1078-0432.CCR-13-2173","article-title":"MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array","volume":"20","author":"Albiges","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annpat.2020.02.022_bib0800","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/1727","article-title":"Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas","volume":"20","author":"Zhuang","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.annpat.2020.02.022_bib0805","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41581-018-0059-6","article-title":"Renal disease in tuberous sclerosis complex: pathogenesis and therapy","volume":"14","author":"Lam","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/TACG.S90262","article-title":"Genetics of tuberous sclerosis complex: implications for clinical practice","volume":"10","author":"Caban","year":"2017","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.annpat.2020.02.022_bib0815","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00000478-200202000-00006","article-title":"Renal Disease in Adults With TSC2\/PKD1\u00a0Contiguous Gene Syndrome","volume":"26","author":"Martignoni","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0820","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","article-title":"TuberOus SClerosis registry to increase disease Awareness (TOSCA) \u2013 baseline data on 2093\u00a0patients","volume":"12","author":"Kingswood","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.annpat.2020.02.022_bib0825","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.annpat.2020.02.022_bib0830","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/PAS.0b013e318206f2a9","article-title":"Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: A clinicopathologic study of 41\u00a0cases: Detailed assessment of morphology and risk stratification","volume":"35","author":"Nese","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0835","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.purol.2014.08.115","article-title":"\u00c9tude anatomo-clinique r\u00e9trospective d\u2019une s\u00e9rie de 17\u00a0cas de carcinomes r\u00e9naux \u00e0 stroma leiomyomateux identifiant une association forte avec la Scl\u00e9rose Tub\u00e9reuse de Bourneville","volume":"24","author":"Verkarre","year":"2014","journal-title":"Prog En Urol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0840","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cjp2.104","article-title":"Atypical tuberous sclerosis complex presenting as familial renal cell carcinoma with leiomyomatous stroma","volume":"4","author":"Bah","year":"2018","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.annpat.2020.02.022_bib0845","article-title":"\u00ab\u00a0Renal Cell Carcinoma With Leiomyomatous Stroma\u00a0\u00bb Harbor Somatic Mutations of TSC1, TSC2, MTOR, and\/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18\u00a0Sporadic Tumors Supports a Distinct Entity","author":"Shah","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0850","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2018.06.007","article-title":"Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma","volume":"74","author":"Mehra","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0855","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.ejhg.5200289","article-title":"Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations","volume":"7","author":"Nelen","year":"1999","journal-title":"Eur J Hum Genet EJHG"},{"key":"10.1016\/j.annpat.2020.02.022_bib0860","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fgene.2018.00353","article-title":"Early Onset Multiple Primary Tumors in Atypical Presentation of Cowden Syndrome Identified by Whole-Exome-Sequencing","volume":"9","author":"Cavaill\u00e9","year":"2018","journal-title":"Front Genet"},{"key":"10.1016\/j.annpat.2020.02.022_bib0865","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime Cancer Risks in Individuals with Germline PTEN Mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annpat.2020.02.022_bib0870","article-title":"Tissue-specific significance of BAP1\u00a0gene mutation in prognostic prediction and molecular taxonomy among different types of cancer","volume":"399","author":"Wang","year":"2017","journal-title":"Tumor Biol"},{"key":"10.1016\/j.annpat.2020.02.022_bib0875","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1\u00a0mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.annpat.2020.02.022_bib0880","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/jnci\/djy171","article-title":"Comprehensive Study of the Clinical Phenotype of Germline BAP1\u00a0Variant-Carrying Families Worldwide","volume":"110","author":"Walpole","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.annpat.2020.02.022_bib0885","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.urology.2018.11.013","article-title":"CDC73\u00a0Germline Mutation in a Family With Mixed Epithelial and Stromal Tumors","volume":"124","author":"Vocke","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.annpat.2020.02.022_bib0890","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.annpat.2020.02.022_bib0895","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/gcc.20403","article-title":"Characterization of a 3;6\u00a0translocation associated with renal cell carcinoma","volume":"46","author":"Foster","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.annpat.2020.02.022_bib0450","first-page":"1758","article-title":"Papillary Thyroid Carcinoma Associated with Papillary Renal Neoplasia: Genetic Linkage Analysis of a Distinct Heritable Tumor Syndrome","volume":"85","author":"Malchoff","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649820300584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649820300584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:34:37Z","timestamp":1759332877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649820300584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0242649820300584"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2020.02.022","relation":{},"ISSN":["0242-6498"],"issn-type":[{"value":"0242-6498","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les cancers du rein h\u00e9r\u00e9ditaires vus par le pathologiste en 2020","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2020.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}